Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1
Human indoleamine 2,3-dioxygenase 1 (hIDO1) is an immunotherapeutic target for cancer therapy. Here, the authors present the substrate-, inhibitor- and effector-bound hIDO1 crystal structures, which give insights into the mechanism and reveal a second small molecule binding site, which is of interes...
Guardado en:
Autores principales: | Ariel Lewis-Ballester, Khoa N. Pham, Dipanwita Batabyal, Shay Karkashon, Jeffrey B. Bonanno, Thomas L. Poulos, Syun-Ru Yeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f8b733a4df2546f48fc72aa65deeac3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
por: Corina Bello, et al.
Publicado: (2021) -
Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.
por: Shamaila Munir, et al.
Publicado: (2012) -
Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
por: Lingyan Xu, et al.
Publicado: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
por: V. A. Kozlov, et al.
Publicado: (2017) -
Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells
por: Mouratidis PX, et al.
Publicado: (2015)